Autoimmune and Paraneoplastic Channelopathies

Neurotherapeutics

Volumn 4, Issue 2, 2007, Pages 305-314

  Vernino, Steven ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

antigenic modulation; Autoantibodies; lung cancer; neuromuscular junction; pyridostigmine; thymoma

Indexed keywords

3,4 DIAMINOPYRIDINE; AUTOANTIBODY; AZATHIOPRINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR ANTIBODY; CYCLOPHOSPHAMIDE; EDROPHONIUM; GABAPENTIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PHENYTOIN; PYRIDOSTIGMINE; STEROID;

ARTICLE; AUTOIMMUNE AUTONOMIC GANGLIONEUROPATHY; CEREBELLAR ATAXIA; CHANNELOPATHY; CLINICAL FEATURE; EATON LAMBERT SYNDROME; HUMAN; IMMUNOMODULATION; LUNG CANCER; MORVAN SYNDROME; MYASTHENIA GRAVIS; MYOKYMIA; NEUROMUSCULAR SYNAPSE; NEUROPSYCHIATRIC LUPUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC CEREBELLAR ATAXIA; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASMUSSEN SYNDROME; STEROID RESPONSIVE ENCEPHALITIS; SYMPTOM; THYMOMA;

ANTIBODIES; AUTOIMMUNE DISEASES; CALCIUM CHANNELS; CHANNELOPATHIES; HUMANS; MUSCLE, SKELETAL; PARANEOPLASTIC POLYNEUROPATHY; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, NICOTINIC;

EID: 33947521640     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.01.007     Document Type: Article

References (68)

1. Drachman D. Myasthenia gravis. N Engl J Med 330 (1994) 1797-1810
2. Albert M.L., and Darnell R.B. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4 (2004) 36-44
3. Oguro-Okano M., Griesmann G.E., Wieben E.D., Slaymaker S.J., Snutch T.P., and Lennon V.A. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 67 (1992) 1150-1159
4. Sciamanna M.A., Griesmann G.E., Williams C.L., and Lennon V.A. Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma. J Neurochem 69 (1997) 2302-2311
5. Drachman D.B. How to recognize an antibody-mediated autoimmune disease: criteria. In: Waksman B.H. (Ed). Immunologic mechanisms in neurologic and psychiatric disease (1990), Raven Press, New York 183-186
6. Engel A.G. The therapy of congenital myasthenic syndromes. Neurotherapeutics 4 (2007) 252-257
7. Vernino S., and Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10 (2004) 7270-7275
8. Lambert E.H., Lindstrom J.M., and Lennon V.A. End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann N Y Acad Sci 274 (1976) 300-318
9. Patrick J., and Lindstrom J. Autoimmune response to acetylcholine receptors. Science 180 (1973) 871-872
10. Lindstrom J.M., Engel A.G., Seybold M.E., Lennon V.A., and Lambert E.H. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J Exp Med 144 (1976) 739-753
11. Xu W., Gelber S., Orr-Urtreger A., et al. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 96 (1999) 5746-5751
12. Richardson C.E., Morgan J.M., Jasani B., et al. Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit. Gastroenterology 121 (2001) 350-357
13. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., and Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343 (2000) 847-855
14. Suarez G.A., Fealey R.D., Camilleri M., and Low P.A. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 44 (1994) 1675-1682
15. Sandroni P., Vernino S., Klein C.M., et al. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol 61 (2004) 44-48
16. Klein C.M., Vernino S., Lennon V.A., et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol 53 (2003) 752-758
17. Goldstein D., Holmes C., Dendi R., Li S.-T., Brentzel S., and Vernino S. Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res 12 (2002) 281-285
18. Schroeder C., Vernino S., Birkenfeld A.L., et al. Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353 (2005) 1585-1590
19. Vernino S., Adamski J., Kryzer T.J., Fealey R.D., and Lennon V.A. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50 (1998) 1806-1813
20. Vernino S., Cheshire W.P., and Lennon V.A. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci 88 (2001) 187-192
21. Singer W., Opfer-Gehrking T.L., McPhee B.R., Hilz M.J., Bharucha A.E., and Low P.A. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 74 (2003) 1294-1298
22. Lennon V.A., Ermilov L.G., Szurszewski J.H., and Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111 (2003) 907-913
23. Vernino S., Ermilov L.G., Sha L., Szurszewski J.H., Low P.A., and Lennon V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci 24 (2004) 7037-7042
24. Vernino S., Low P.A., and Lennon V.A. Experimental autoimmune autonomic neuropathy. J Neurophysiol 90 (2003) 2053-2059
25. Pietroban D. Familial hemiplegic migraine. NeuroRx2007;4.
26. Kordasiewicz H.B., and Gomez C.M. Molecular pathogenesis of spinocerebellar ataxia type 6 (SCA6). Neurotherapeutics 4 (2007) 285-294
27. Lambert E.H., and Lennon V.A. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities. Muscle Nerve 11 (1988) 1133-1145
28. Waterman S., Lang B., and Newsom-Davis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 42 (1997) 147-156
29. McEvoy K.M. Diagnosis and treatment of Lambert-Eaton myasthenic syndrome. Neurol Clin 12 (1994) 387-399
30. Rees J.H., Hain S.F., Johnson M.R., et al. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain 124 (2001) 2223-2231
31. Lennon V.A., Kryzer T.J., Griesmann G.E., et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332 (1995) 1467-1474
32. Clouston P.D., Saper C.B., Arbizu T., et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42 (1992) 1944-1950
33. Graus F., Lang B., Pozo-Rosich P., Saiz A., Casamitjana R., and Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59 (2002) 764-766
34. Fukuda T., Motomura M., Nakao Y., et al. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 53 (2003) 21-28
35. Rajakulendran S., Schorge S., Kullmann D.M., and Hanna M.G. Neurotherapeutics 4 (2007) 258-266
36. Zuberi S.M., Eunson L.H., Spauschus A., et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122 (1999) 817-825
37. Hart I.K., Maddison P., Newsom-Davis J., Vincent A., and Mills K.R. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 (2002) 1887-1895
38. Vernino S., and Lennon V.A. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 26 (2002) 702-707
39. Newsom-Davis J., and Mills K.R. Immunological associations of acquired neuromyotonia (Isaacs' syndrome) report of five cases and literature review. Brain 116 (1993) 453-469
40. Auger R.G. AAEM Minimonograph #44: diseases associated with excess motor unit activity. Muscle Nerve 17 (1994) 1250-1263
41. Tahmoush A., Alonso R., Tahmoush G., and Heiman-Patterson T. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 41 (1991) 1021-1024
42. Ansevin C., and Agamanolis D. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol 53 (1996) 197-199
43. Kleopa K.A., Elman L.B., Lang B., Vincent A., and Scherer S.S. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 129 (2006) 1570-1584
44. Shillito P., Molenaar P.C., Vincent A., et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 38 (1995) 714-722
45. Sinha S., Newsom-Davis J., Mills K., Byrne N., Lang B., and Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338 (1991) 75-77
46. Madrid A., Gil-Peralta A., Gil-Neciga E., Gonzalez J., and Jarrin S. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol 243 (1996) 350-353
47. Riche G., Trouillas P., and Bady B. Improvement of Isaacs' syndrome after treatment with azathioprine. J Neurol Neurosurg Psychiatry 59 (1995) 448
48. Tomimitsu H., Arimura K., Nagado T., et al. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia. Ann Neurol 56 (2004) 440-444
49. Hart I.K., Waters C., Vincent A., et al. Autoantibodies detected to expressed potassium channels are implicated in neuromyotonia. Ann Neurol 41 (1997) 238-246
50. Arimura K. Antibodies directed to voltage-gated potassium channels in sera from acquired neuromyotonia and related disorders. [in Japanese]. Rinsho Shinkeigaku 39 (1999) 1235-1236
51. Liguori R., Vincent A., Clover L., et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124 (2001) 2417-2426
52. Lawn N.D., Westmoreland B.F., Kiely M.J., Lennon V.A., and Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78 (2003) 1363-1368
53. Josephs K.A., Silber M.H., Fealey R.D., Nippoldt T.B., Auger R.G., and Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 21 (2004) 440-445
54. Barber P.A., Anderson N.E., and Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology 54 (2000) 771-772
55. Buckley C., Oger J., Clover L., et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50 (2001) 73-78
56. Schott J.M., Harkness K., Barnes J., della Rocchetta A.I., Vincent A., and Rossor M.N. Amnesia, cerebral atrophy, and autoimmunity. Lancet 361 (2003) 1266 [Erratum. Lancet 2004;363:86]
57. Pozo-Rosich P., Clover L., Saiz A., Vincent A., and Graus F. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 54 (2003) 530-533
58. Thieben M.J., Lennon V.A., Boeve B.F., Aksamit A.J., Keegan M., and Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62 (2004) 1177-1182
59. Vincent A., Buckley C., Schott J.M., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 (2004) 701-712
60. McKnight K., Jiang Y., Hart Y., et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65 (2005) 1730-1736
61. Rogers S., Andrews P., Gahring L., et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265 (1994) 648-651
62. Mantegazza R., Bernasconi P., Baggi F., et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131 (2002) 179-185
63. Bien C.G., and Bauer J. T-cells in human encephalitis. NeuroMolecular Med 7 (2005) 243-254
64. Watson R., Jepson J.E., Bermudez I., et al. Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 65 (2005) 1802-1804
65. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7 (2001) 1189-1193
66. Omdal R., Brokstad K., Waterloo K., Koldingsnes W., Jonsson R., and Mellgren S.I. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 12 (2005) 392-398
67. Kowal C., DeGiorgio L.A., Nakaoka T., et al. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
68. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477